Mirtazapine Tablet, Film Coated
Product Images NDC 71610-475

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 15 mg (71610 0475 15)

Bottle Label 15 mg (71610 0475 15)
Mirtazapine 15 mg film-coated tablets label showing the product name, strength, dosage form, and quantity (15 tablets). The label includes storage instructions, manufacturer (AlphaPharm Pty Ltd., Australia), and labeler (Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN). It also features barcodes and dispensing information such as RX only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Mirtazapine Structural Formula (Image 04)

Mirtazapine Structural Formula (Image 04)
Chemical structure diagram of mirtazapine, an active pharmaceutical ingredient. The diagram shows the molecular framework with nitrogen atoms and ring structures characteristic of the mirtazapine molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.